Kolexia
Gilletta De Saint Joseph Cyrielle Gastro-entérologie
Gilletta De Saint Joseph Cyrielle
Gastro-entérologie
Hôpital Rangueil
Toulouse, France
44 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies inflammatoires intestinales Ulcère Colite Rectocolite hémorragique Maladie de Crohn Maladies intestinales Manifestations buccales Fistule Complications de la grossesse

Collaborateurs

Voir plus
Moreau Jacques
Moreau Jacques
Hôpital Rangueil, Toulouse, France
Bonnaud Guillaume
Bonnaud Guillaume
Cl Ambroise Pare Toulouse, Toulouse, France
Faure Patrick
Faure Patrick
Centre Des Maladies De L'appareil Digestif, Toulouse, France
Staumont Ghislain
Staumont Ghislain
Scp Gastro-procto 31, Quint-Fonsegrives, France

Industries

Voir plus
Janssen
69 collaboration(s)
Dernière en 2023
Abbvie
63 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
29 collaboration(s)
Dernière en 2023
Galapagos SASU
9 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
ABTECT - Maintenance: A Randomized, Double-blind, Multicenter Phase III Study to Evaluate the Long-term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis : A Double Blinded Randomized Clinical Trial
Essai Clinique (CHU Rennes)   20 novembre 2023
SPACIFIX: Comparison of Trough Level-based Spacing and Clinical-based Spacing of Infliximab Infusions in Patients With Inflammatory Bowel Disease in Deep Remission; A Prospective, Multicenter, Open-label, Randomized, Controlled Study
Essai Clinique (CHU Montpellier)   02 mai 2023
Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters.
mAbs   04 novembre 2021
Facteurs prédictifs d’invalidité dans les MICI : une étude du GETAID
Edimark   22 mars 2021
How Oral Specialists Can Help Diagnose and Manage Extra-Digestive Inflammatory Bowel Disease Complications.
Case reports in gastroenterology   04 mars 2021
Optimization of biologics to reduce treatment failure in inflammatory bowel diseases.
Current opinion in pharmacology   15 septembre 2020
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
Alimentary pharmacology & therapeutics   06 novembre 2019
Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).
Alimentary pharmacology & therapeutics   07 septembre 2018